SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001072613-14-000010
Filing Date
2014-01-23
Accepted
2014-01-23 13:11:18
Documents
1
Group Members
DAVID M. MOTTFOREST BASKETTHARRY R. WELLERKRISHNA S. KOLLURIMICHAEL JAMES BARRETTNEA 13 GP LTDNEA PARTNERS 10 LIMITED PARTNERSHIPNEA PARTNERS 13 L.P.NEW ENTERPRISE ASSOCIATES 13 L.P.PATRICK J. KERINSPETER J. BARRISRAVI VISWANATHANRYAN D. DRANTSCOTT D. SAN

Document Format Files

Seq Description Document Type Size
1 GLYCOMIMETICS, INC. glyco-sch13d_17605.htm SC 13D 464704
  Complete submission text file 0001072613-14-000010.txt   466561
Mailing Address
Business Address 1119 ST PAUL STREET BALTIMORE MD 21202 4102440115
NEW ENTERPRISE ASSOCIATES 10 L P (Filed by) CIK: 0001132326 (see all company filings)

IRS No.: 061590878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879 240-243-1201
GLYCOMIMETICS INC (Subject) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87811 | Film No.: 14542314
SIC: 2834 Pharmaceutical Preparations